VERIFIEDMint Markets·29 Sept 2026positive

Zydus hits 52-week high, can the optimism continue?

AI Summary

·Zydus Lifesciences has seen a 32% increase in its stock value in 2026.
·Favorable US FDA inspections, resilient India growth, and a strong pipeline have contributed to the stock's performance.
·Potential risks include weakness in the US market and pressure on profit margins.